U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients ...
that target one contributor to Alzheimer’s — sticky amyloid plaque buildup in the brain. Questions remain about which ...
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
The FDA's approval is the first confirmation that a drug targets the underlying causes of Alzheimer's disease. Chuck Mann, father, grandfather, and mechanical engineer, his son Matthew cherished the ...
"In our study, maternal history of dementia increased their children’s risk of having preclinical AD, while paternal history ...
Cooling economic data raised rate-cut hopes. Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in ...
Pickens County Sheriff's Office have found human remains in a heavily wooded area in Liberty, South Carolina. On Saturday, ...
The FDA has approved a new Alzheimer's drug that offers hope for a slower cognitive decline. It's only the second drug that's ...
Rochester, N.Y. (WHAM) — Pittsford resident Tamara Minter has been a longtime advocate who has raised awareness about ...
Click here to get the story. Eli Lilly’s Kisunla (donanemab) is a monthly injection for adults with early symptomatic ...
While reading a morning newspaper, Grieser came across an advertisement for a clinical trial looking for older participants to receive a treatment aimed at delaying memory loss before noticeable signs ...
Buying legitimate Back it Up Terry goods from family-approved sources helps the family pay for the gas used in the van. "It's ...